Yubo International Biotech Limited Stock Other OTC
Equities
YBGJ
US9883661004
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | 0.1 | Sales 2023 | 0.6 | Capitalization | 35.95M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | -1M | EV / Sales 2022 | 116,560,264 x |
Net Debt 2022 | 772K | Net Debt 2023 | 386K | EV / Sales 2023 | 60,084,725 x |
P/E ratio 2022 |
-9.36
x | P/E ratio 2023 |
-30.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.63% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 19-12-31 |
1st Jan change | Capi. | |
---|---|---|
+22.98% | 45.01B | |
+47.19% | 40.96B | |
-5.78% | 38.62B | |
+36.02% | 32.6B | |
-7.79% | 27.49B | |
+17.93% | 27.17B | |
+48.37% | 14.61B | |
+40.42% | 12.95B | |
-2.15% | 11.36B |